• The Korean Journal of Pharmacology
• /
• v.28 no.2
• /
• pp.171-179
• /
• 1992

Effects of a $M_1$ receptor antagonist, pirenzepine, a $M_2$ receptor antagonist, AF-DX116, and a nicotinic receptor antagonist, mecamylamine on the pressor responses to preganglionic sympathetic nerve stimulation (PNS) and McN-A-343 and DMPP in spinal (pithed) rabbits were investigated, in order to elucidate a functional role of $M_1$, $M_2$ and nicotinic receptors in ganglionic transmission. Pirenzepine and AF-DX116 selectively inhibited the McN-A-343-induced pressor response in chlorisondamine-treated rabbit and the BCh-induced bradycardia, respectively. Electrical stimulations of preganglionic sympathetic outflow at T8 level produced increases in blood pressure. Pirenzepine $(3\;{\mu}g/kg)$ significantly inhibited the PNS-induced pressor response and the degree of inhibition was not changed by increasing the doses to $100\;{\mu}g/kg$. AF-DX116 $(100\;{\mu}g/kg)$ had no effect on the PNS-induced pressor response. Mecamylamine inhibited the PNS-induced pressor response in a dose-dependent manner. The inhibitory action of mecamylamine was significantly augmented by combined-treatment with pirenzepine $(30\;{\mu}g/kg)$ but AF-DX116 $(100\;{\mu}g/kg)$ did not affect the inhibitory action of mecamylamine. McN-A-343 and DMPP elicited pressor response in the spinal rabbit. Pirenzepine and AF-DX116 dose-dependently inhibited the McN-A-343-induced pressor response but they did not affect DMPP-induced pressor response. Mecamylamine inhibited both pressor responses induced by McN-A-343 and DMPP. These results suggest that not only nicotinic receptors but also $M_1$ receptors play a facilitatory role in ganglionic transmission but $M_2$ receptors do not contribute the transmission in spinal (pithed) rabbits.

• Applied Microscopy
• /
• v.48 no.1
• /
• pp.17-26
• /
• 2018

The characteristic features of the arachnid central nervous system (CNS) are related to its body segmentation, and the body in the Opiliones appears to be a single oval structure because of its broad connection between two tagmata (prosoma and opisthosoma). Nevertheless, structural organization of the ganglionic neurons and nerves in the harvestman Leiobunum japonicum is quite similar to the CNS in most other arachnids. This paper describes the fine structural details of the main groups of neuropiles in the CNS ganglia revealed by the transmission electron microscopy. In particular, electron-microscopic features of neural clusters in the main neuroganglia of the CNS (supraesophageal ganglion, protocerebral ganglion, optic lobes, central body, and subesophageal ganglion) could provide indications for the nervous pathways associated with nerve terminations and plexuses. The CNS of this harvestman consists of a supraesophageal ganglion (brain) and a subesophageal mass, and there are no ganglia in the abdomen. Cell bodies of neuroganglia are found in the periphery, but central parts of the ganglia are mostly fibrous in all ganglia. Neuroglial cells occupy the spaces left by nerve cells. Since the nerve cells in the ganglia are typical composed of monopolar neurons, axons and dendrites of neurons are distributed along the same direction.

• Journal of Chest Surgery
• /
• v.33 no.3
• /
• pp.268-272
• /
• 2000

Thoracic sympathicotomy has been used safely and successfully to treat essential hyperhidrosis. However, it has been difficult to treat compansatory hyperhidrosis after thoracic sympathicotomy and focal hyperhidrosis. The sweat glands were innervated by post-ganglionic sympathetic fibers with acetylcholic serving as the transmitter. Botulinum A toxin has been reported to block neuro-transmission at the cholinergic autonomic nerve terminals. Prospecting its effect for the sweat gland, we treated 5 patients with focal hyperhidrosis with botulinum A toxin. Three patients received bilateral thoracic sympathectomy (1 case) and sympathicotomy(2 case) via VAT. The hyperhidrosis area was marked with betadine and was subdivided into squares of 2$\times$2 cm(4$\textrm{cm}^2$) each. Botulinum A toxin was injected intracutaneously in a dosage of 2.5U/0.1ml(100U/4ml) /4$\textrm{cm}^2$. A total dose of 100U of Botulinum A toxin was injected into the affected sites. Subjective assessment of sweat production by the patients using a visual analogue scale showed a 20~70% improvement. During the follow-up period, no toxic effects were observed.